The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Thu, 02nd Apr 2020 13:07

(Alliance News) - The following is a round-up of company director and manager changes announced on Wednesday and Thursday and not separately reported by Alliance News:

----------

Iofina PLC - Hires Mary Fallin as non-executive director. Fallin is the former governor of the US state of Oklahoma, where Iofina operates four iodine extraction plants. "Throughout her time in politics she has been a great advocate of small and medium-sized enterprises like Iofina and so to have her join the team during this next phase of growth is really exciting for us," said Iofina Chief Executive Officer Tom Becker.

----------

BAE Systems PLC - Hires former Johnson & Johnson executive Jane Griffiths as non-executive director from Wednesday. Last role was as global head of Actelion, leading the integration of the Swiss biotech company following its acquisition by the US's J&J. Nick Rose agrees to remain as non-executive director for another year.

----------

Serinus Energy PLC - Hires former BP PLC geophysicist Andy O'Donovan as chief operating officer from Wednesday.

----------

Ingenta PLC - Hires Sebastian White as non-executive director, as Max Royde steps down, both immediately. White is investment director for Kestrel Partners LLP, a 27% shareholder of Ingenta.

----------

RDL Realisation PLC - Dominik Dolenec resigns as director in accordance with terms of the standstill agreement between Oaktree Value Equity Holdings LP and LIM Advisors (London) Ltd.

----------

Ince Group PLC - Financial Controller Simon Oakes steps up to chief financial officer, as announced back in January, with Christopher Yates stepping down. Anthony Edwards steps down as non-executive chair and as director, with Senior Non-Executive Director David Furt taking on the chair.

----------

KRM22 PLC - CFO Kim Suter added to the board immediately as executive director. Karen Bach, a founder of KRM22 and former COO, steps down as non-executive director.

----------

Hargreaves Services PLC - Hires Christopher Jones as non-executive director, from Wednesday. Jones is a veteran of the UK commercial property market, founding Manchester-based Christopher Dee LLP.

----------

e-Therapeutics PLC - Hires Laura Roca-Alonso as chief business officer. Was head of Corporate Development at Silence Therapeutics PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Aug 2019 18:48

Societe Generale Builds 5% Interest In Silence Therapeutics

(Alliance News) - Silence therapeutics PLC said on Thursday that French investment bank Societe Generale SA has a 5% stake in the company.It was not disclosed how many shares, if any, that

Read more
29 Jul 2019 11:43

Silence Therapeutics Appoints Mallinckrodt Executive Romano To Board

LONDON (Alliance News) - Silence Therapeutics PLC said Monday that Steven Romano has joined as non-executive director, as part of the company's collaboration and equity investment by has USD5

Read more
18 Jul 2019 13:23

Silence Therapeutics Surges As It Signs Major Deal With Mallinckrodt

(Alliance News) - New York-listed Mallinckrodt PLC has invested USD5 million into Silence Therapeutics PLC, the two announced on Thursday, as part of a collaboration worth potentially hundreds of

Read more
18 Jun 2019 16:00

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 19 JuneTarsus GroupCadongan PetroleumWhitbreadSagaN4 20

Read more
28 May 2019 13:26

Silence Therapeutics enters into collaboration with Genomics England

(Sharecast News) - Novel therapeutics developer Silence Therapeutics has entered into a collaboration with Genomics England for the investigation of novel targets involved in human disease, it announced on Tuesday.

Read more
25 Apr 2019 12:32

Silence Therapeutics Reappoints Ross As Chair; Changes Non-Execs

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday it had reappointed Iain Ross as chair of the genetic medicines firm with immediate effect, alongside the hiring of another - who as

Read more
18 Apr 2019 10:48

Silence Therapeutics Interim Finance Chief Quinn Appointed Permanently

LONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a permanent basis with immediate effect.He will

Read more
18 Apr 2019 09:27

Silence Therapeutics makes Rob Quinn permanent CFO

(Sharecast News) - Biotechnology company Silence Therapeutics said it had appointed Rob Quinn to take over as its full-time chief financial officer, effective immediately.

Read more
16 Apr 2019 12:06

Silence Therapeutics Interim Chair Departs, New Head Of R&D Joins

LONDON (Alliance News) - Silence Therapeutics PLC on Tuesday reported a number of changes to its board and operational team, including its interim chair.Andy Richards has been serving as a

Read more
11 Mar 2019 10:49

Silence Therapeutics Loss Widens After Share Disposal Year Before

LONDON (Alliance News) - Silence Therapeutics PLC on Monday said its loss widened considerably in its most recent year after a gain on the disposal of its shares in Arrowhead Pharmaceuticals Inc a

Read more
11 Mar 2019 10:36

Silence Therapeutics losses widen as it progresses drug candidates

(Sharecast News) - Drug development company Silence Therapeutics announced its unaudited preliminary results for the year ended 31 December on Monday, reporting a loss after tax of £18.4m, widening form £1.6m a year earlier.

Read more
15 Jan 2019 11:20

Silence Therapeutics' Lead Candidate Drug Gets Orphan Status In Europe

LONDON (Alliance News) - Silence Therapeutics on Tuesday said its SLN124 main candidate drug has been designated as an orphan drug in Europe for the treatment of beta-thalassemia.Shares in

Read more
9 Jan 2019 10:40

Silence Therapeutics CFO steps down

(Sharecast News) - Silence Therapeutics chief financial officer David Ellam stepped down from the group with immediate effect on Wednesday.

Read more
9 Jan 2019 09:26

Silence Therapeutics Chief Financial Officer David Ellam Resigns

LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday Chief Financial Officer David Ellam has resigned from the serious disease treatment firm with immediate effect.Ellam - CFO -

Read more
11 Oct 2018 13:27

US Patent Board Rejects Alnylam's Claim Against Silence Therapeutics

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday the US Patent Trial & Appeal Board rejected Alnylam Pharmaceutics Inc's petition against newly-issued Silence filed a total

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.